#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cervix carcinoma recurrent Chronic lymphocytic leukaemia refractory Glomerulonephritis membranous Oesophageal squamous cell carcinoma stage II Central nervous system neoplasm Bronchopulmonary dysplasia Hyperchylomicronaemia Basal cell naevus syndrome Acute myeloid leukaemia refractory Thalassaemia Neuroendocrine tumour Immune-mediated renal disorder Gastrointestinal neuroendocrine tumour Drug eruption Cytokine release syndrome More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma stage II – Diagnostics Wiskott-Aldrich syndrome – Basic Information Friedreich’s ataxia – Basic Information Langerhans cell sarcoma – Treatment Haemolytic uraemic syndrome – Treatment SAPHO syndrome MELAS syndrome – Diagnostics Mucopolysaccharidosis II – Treatment Hereditary motor and sensory neuropathy – Treatment Inclusion body myositis – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Img-007 Tivozanib Acetazolamide Tovinontrine Monalizumab SODIUM FUSIDATE Peginterferon Beta-1A F125/10 Human Coagulation Factor Vii Metamizole Amikacin Dacarbazine Gad20-209-Fsp-A2 Altizide GSKVX000000070250 64CU-PSMA I&T Psma-11 Atropine Sulfate Monohydrate Flutafuranol (18F) Bms-986449-03 More therapies…

    Learn about Your Condition

    Gastrectomy Cervix carcinoma stage III Toxic nodular goitre Primary adrenal insufficiency Demyelination Laryngeal cancer Dermatitis atopic Cervix carcinoma stage II Psychological trauma Laparoscopic surgery Renal injury Kearns-Sayre syndrome Colitis Cervix carcinoma stage I Hairy cell leukaemia recurrent More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Primary biliary cholangitis

  • Study of Seladelpar Treatment in Patients with Primary Biliary Cholangitis and Compensated Cirrhosis

    Recruiting

    3 1
    Investigated Drugs:
    • Seladelpar
    Austria Belgium Czechia Denmark France Germany +7

  • Study on Bezafibrate for Patients with Primary Biliary Cholangitis Not Responding Well to Ursodeoxycholic Acid

    Recruiting

    3 1 1
    Investigated Diseases:
    • Primary biliary cholangitis
    Investigated Drugs:
    • Bezafibrate
    France

  • Study of Elafibranor for Adults with Primary Biliary Cholangitis

    Recruiting

    3 1
    Investigated Diseases:
    • Primary biliary cholangitis
    Investigated Drugs:
    • Elafibranor
    Belgium Bulgaria Czechia Denmark France Greece +8

  • Study on the Safety and Effectiveness of Saroglitazar Magnesium for Patients with Primary Biliary Cholangitis

    Not recruiting

    4 1
    Investigated Drugs:
    • SAROGLITAZAR HEMIMAGNESIUM
    Iceland

  • Study on the Long-Term Safety of Obeticholic Acid and Bezafibrate for Patients with Primary Biliary Cholangitis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Primary biliary cholangitis
    Investigated Drugs:
    • Bezafibrate
    • Obeticholic Acid
    Belgium Croatia Czechia Estonia France Germany +6

  • Study on the Effects of Bezafibrate and Obeticholic Acid for Patients with Primary Biliary Cholangitis

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Primary biliary cholangitis
    Investigated Drugs:
    • Bezafibrate
    • Obeticholic Acid
    Italy
1 2 3
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!